Pharmacologic Considerations for Patients With Concussion
|
Question |
Answer/Pertinent Information |
|
What are the symptoms of a concussion? |
Symptoms of a concussion (also called mild traumatic brain injury) can include headache, nausea and/or vomiting, vision problems, dizziness, cognitive impairment, irritability, anxiety, and sleep problems.1 Symptoms typically show up right away; however, they can develop hours to days following a head injury.1 Patients with “alarm” symptoms (e.g., loss of consciousness, seizures, repeated vomiting) should seek immediate medical attention.2 Resolution of concussion symptoms typically occurs within one to four weeks.1,2
Patients with concussions may exhibit new symptoms, concurrent injury symptoms (e.g., whiplash), or they may have worsening symptoms related to prior chronic issues (e.g., ADHD, depression, migraines, anxiety).5
|
|
How can headache be treated in the early stages of a concussion? |
Acetaminophen or ibuprofen can be used to treat headache after a concussion.1,4,13
|
|
Which meds should be avoided in patients who have a concussion? |
Patients with a concussion should try to avoid meds that may worsen, mimic, or mask symptoms of the concussion or that may interfere with mental status changes and medical evaluations (e.g., benzodiazepines, high-dose analgesics, other sedatives).5 |
|
How should patients with a concussion who are taking antithrombotics be managed? |
Patients taking antithrombotics (e.g., aspirin, warfarin, clopidogrel, etc) may be at an increased risk of intracranial bleeding following a concussion.
|
|
Are meds recommended to treat acute concussion or post-concussion syndrome? |
There are no recommended medications for the specific treatment of either acute concussion or post-concussion syndrome due a lack of efficacy and safety evidence.1,4,5 However, meds are sometimes used to treat symptoms that accompany concussion (e.g., sleep disorders, migraines, depression). These conditions are generally managed with the same meds that are used in patients without a concussion.4 |
|
Which meds have been studied for use in patients with post-concussion syndrome? |
There are multiple studies using various medications (e.g., methylphenidate, sertraline, ondansetron, amitriptyline, topiramate, amantadine, and melatonin) in patients with concussion; however, they are of low quality and generally lack clinically meaningful data.1,4,7,8,9,15 |
|
What supplements or home remedies are promoted as treatments for concussion? |
There are many supplements, homeopathic products, essential oils, and herbal teas that are promoted to help patients with concussions. These products are not recommended for the treatment of concussion due to a lack of efficacy and safety data.10,11 Examples include horse chestnut, piracetam, ascorbic acid (vitamin C), vitamin E, magnesium, riboflavin, coenzyme Q10, B vitamins, omega-3 fatty acids, curcumin (turmeric), vitamin D, progesterone, N-methyl-D-aspartate, exogenous ketones, and dietary manipulations (e.g., ketogenic diet).1,9-11
|
References
- Halstead ME, Walter KD, Moffatt K, Council on Sports Medicine and Fitness. Sport-related concussion in children and adolescents. Pediatrics 2018;142:e2013074.
- Government of Canada. Concussion: symptoms and treatment. October 10, 2021. https://www.canada.ca/en/public-health/services/diseases/concussion-sign-symptoms.html. (Accessed October 14, 2021).
- Mayo Clinic. Persistent post-concussive symptoms (post-concussion syndrome). October 6, 2020. https://www.mayoclinic.org/diseases-conditions/post-concussion-syndrome/symptoms-causes/syc-20353352. (Accessed October 14, 2021).
- Scorza KA, Cole W. Current concepts in concussion: initial evaluation and management. Am Fam Physician 2019;99:426-34.
- Ontario Neurotrauma Foundation. Guideline for concussion/mild traumatic brain injury & prolonged symptoms, Healthcare professional version, third edition, Adults (18+ years of age). May 2018. https://braininjuryguidelines.org/concussion/fileadmin/media/Concussion_guideline_3rd_edition_final.pdf. (Accessed October 14, 2021).
- Babl FE, Tavender E, Dalziel S. On behalf of the Guideline Working Group for the Paediatric Research in Emergency Departments International Collaborative (PREDICT). Australian and New Zealand guideline for mild to moderate head injuries in children 2021. August 5, 2021. https://www.predict.org.au/head-injury-guideline/. (Accessed October 14, 2021).
- Feinberg C, Carr C, Zemek R, et al. Association of pharmacological interventions with symptom burden reduction in patients with mild traumatic brain injury, a systematic review. JAMA Neurol 2021;78:596-608.
- Rabinowitz AR, Watanabe TK. Pharmacotherapy for treatment of cognitive and neuropsychiatric symptoms after mTBI. J Head Trauma Rehabil 2020;35:76-83.
- Kim K, Priefer R. Evaluation of current post-concussion protocols. Biomed Pharmacother 2020;129:110406.
- TRC Healthcare. [Natural Medicines website]. Available at: https://naturalmedicines.therapeuticresearch.com/. (Accessed October 14, 2021).
- Harmon KG, Clugston JR, Dec K, et al. American Medical Society for sports medicine position statement on concussion in sport. Clin J Sport Med 2019;29:87-100.
- Mole B. Researchers find dangerous, FDA-rejected drug in supplements – by reading labels. November 26, 2019. https://arstechnica.com/science/2019/11/researchers-find-dangerous-fda-rejected-drug-in-supplements-by-reading-labels/. (Accessed October 14, 2021).
- Reed N, Zemek R, Dawson J, et al. Living guideline for pediatric concussion care. Last updated March 1, 2021. https://pedsconcussion.com/wp-content/uploads/2021/01/Living-Guideline-for-Diagnosing-and-Managing-Pediatric-Concussion.pdf. (Accessed October 19, 2021).
- University of Michigan Health. Concussion treatment and recovery. https://www.uofmhealth.org/conditions-treatments/brain-neurological-conditions/concussion-treatment-and-recovery. (Accessed October 20, 2021).
- Larsen EL, Ashina H, Iljazi A, et al. Acute and preventive pharmacological treatment of post-traumatic headache: a systematic review. J Headache Pain 2019;20:98.
Cite this document as follows: Clinical Resource, Pharmacologic Considerations for Patients With Concussions. Pharmacist’s Letter/Prescriber’s Letter. November 2021. [371110]